Heparin-induced thrombocytopenia presenting after the cessation of low molecular weight heparin prophylaxis with enoxaparin.
Barratt
S M
SM
Department of Anaesthesia and Pain Management, Sydney University, Royal North Shore Hospital, St Leonards, NSW. sbarratt@mail.usyd.edu.au
Ruff
S J
SJ
Edwards
R C
RC
D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D002809:Chondroitin Sulfates / Q000627:therapeutic use; D003871:Dermatan Sulfate / Q000627:therapeutic use; D004338:Drug Combinations; D017984:Enoxaparin / Q000009:adverse effects*; D005260:Female; D006497:Heparan Sulfate / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D010976:Platelet Count; D011877:Radionuclide Imaging; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000000981:diagnostic imaging; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D017984:Enoxaparin; D006497:Heparan Sulfate; D014859:Warfarin; C035838:danaparoid